<p>(A) Pol II ChIP analysis of the <i>PMA1</i> gene in p53<sup>+</sup> and p53<sup>−</sup> cells. Depicted is a multiplex PCR analysis (resolved on an 8% polyacrylamide gel) of DNA purified from immunoprecipitated chromatin samples isolated from SY1000 (<i>P<sub>GAL1-</sub> p53</i>) and SLY101 (p53<sup>−</sup>) cells subjected to a 2% galactose induction for 0, 60, 120 and 180 min. Immunoprecipitations were conducted using pre-immune (lanes 1, 6) or anti-CTD antiserum (lane 2–5, 7–10). Lane 11, DNA isolated from chromatin used in the ChIPs of lanes 1 and 2. An ORF-free region on chromosome V (<i>ARS504</i>) was co-amplified with the <i>PMA1</i> loci, and serves as a non-specific IP control. (B) Summary of Pol II ChIP assays of the <i>PMA1</...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>All cells are deleted for p53 (even controls) to avoid early replicative senescence. Shown is the...
<p>(<b>A</b>) Relative expression levels of p53 and FHL2-1a in HepG2 cells treated with p53-siRNA wi...
<p>(A) Domain structures of p53<sup>+</sup> and p53<sup>coreΔ</sup>. TA1 and TA2, transactivation do...
<p>(A) Immunoblotting was performed using lysates from <i>Poldip2+/+</i> and <i>Poldip2−/−</i> MEFs ...
<p>(A) Quantitative RT-PCR analysis was performed for each sample in triplicate. The median ΔΔC<sub>...
<p>) (a) ChIP-Seq track showing p53 occupancy at <i>Pax2</i> proximal promoter (Region 1). (b) That ...
<p><b>(A)</b> The relevant nucleotides of the mutated p53 cDNA are shown. At passage 13, an insertio...
<p>MCF10A, MCF10A/OD, and MCF10A/Δp53 cells were incubated with either fresh media (untreated) or 10...
<div><p><b>A</b>. Analysis of exogenously expressed MDM2-FL or MDM2-C in H1299 cells with simultaneo...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>A. Left panel: Western blot analysis of the level of p53, GAPDH and p21 (CDKN1A) in lysates isola...
<p>A) Cycloheximide chase in MCF-7 and MCF-7Skp2B cells was performed for the indicated time and cel...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>(A, C, E, G) The locations of primers used in this assay are shown under the gene structures. (B,...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>All cells are deleted for p53 (even controls) to avoid early replicative senescence. Shown is the...
<p>(<b>A</b>) Relative expression levels of p53 and FHL2-1a in HepG2 cells treated with p53-siRNA wi...
<p>(A) Domain structures of p53<sup>+</sup> and p53<sup>coreΔ</sup>. TA1 and TA2, transactivation do...
<p>(A) Immunoblotting was performed using lysates from <i>Poldip2+/+</i> and <i>Poldip2−/−</i> MEFs ...
<p>(A) Quantitative RT-PCR analysis was performed for each sample in triplicate. The median ΔΔC<sub>...
<p>) (a) ChIP-Seq track showing p53 occupancy at <i>Pax2</i> proximal promoter (Region 1). (b) That ...
<p><b>(A)</b> The relevant nucleotides of the mutated p53 cDNA are shown. At passage 13, an insertio...
<p>MCF10A, MCF10A/OD, and MCF10A/Δp53 cells were incubated with either fresh media (untreated) or 10...
<div><p><b>A</b>. Analysis of exogenously expressed MDM2-FL or MDM2-C in H1299 cells with simultaneo...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>A. Left panel: Western blot analysis of the level of p53, GAPDH and p21 (CDKN1A) in lysates isola...
<p>A) Cycloheximide chase in MCF-7 and MCF-7Skp2B cells was performed for the indicated time and cel...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>(A, C, E, G) The locations of primers used in this assay are shown under the gene structures. (B,...
p53 can adopt two forms in vitro, a latent form that binds naked DNA poorly and an active form that ...
<p>All cells are deleted for p53 (even controls) to avoid early replicative senescence. Shown is the...
<p>(<b>A</b>) Relative expression levels of p53 and FHL2-1a in HepG2 cells treated with p53-siRNA wi...